SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Frequent Flyer Miles-Don't let the turkeys eat them!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: margaret foley who wrote (5)1/11/1999 4:58:00 PM
From: Janet Madison   of 6
 
Hi,
Want to let all posters and lurkers to know that the person going for the clinical trials of Coulter Pharmaceuticals Bexxar treatment is well on the way. He has gone to the hospital 3 times and tomorrow will be the next session. These visits are all preliminary to the January 15th session where he will spend several days in the hospital and the dosage will be increased more than tenfold. This will be the last visit and he will be in remission, God willing.
The best part of this Bexxar trial is that there are few if any side effects. The day after the first small test dose, the swollen leg had gone down so much that he could see his knee for the first time in many months. Also, his lymph nodes in the neck had gone down as well as in other parts of his body. This is so great! His wife is so excited with the good response to the Bexxar.
So, for all of you who wished to help and for all who were praying and cheering them on, a big hug and thank you from me and the family.
Happy New Year!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext